Fig. 6: Forest plot of immunomarker-derived vaccine efficacy (VEIM) and vaccine efficacy against clinical event (shigellosis) (VECE) estimated in the CHIM study population. | npj Vaccines

Fig. 6: Forest plot of immunomarker-derived vaccine efficacy (VEIM) and vaccine efficacy against clinical event (shigellosis) (VECE) estimated in the CHIM study population.

From: Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine

Fig. 6

Graphical representation of Immunomarker-derived VE (VEIM) calculated using the IgG protection threshold proposed by Cohen et al.13. and vaccine efficacy against observed clinical event (VECE), represented by squares with their corresponding 90% confidence intervals (horizontal lines).

Back to article page